Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07498582 · ClinicalTrials.gov registry record · NA
AI Tool to Reduce Clinician Documentation Burden
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT07498582: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT07498582 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07498582, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
This study looks at whether a clinician-facing artificial intelligence (AI) tool can help outpatient doctors spend less time reviewing medical records and documenting care. The tool creates brief summaries of existing medical record information to support routine clinical work. This study examines how use of this tool affects clinicians' workload, time spent in the electronic health record, and overall experience with documentation. The goal is to better understand whether AI documentation support tools can improve efficiency and reduce burden for clinicians in outpatient specialty practice. Eligible UNC outpatient specialists may be invited to complete surveys and, if they qualify, are randomly assigned either to receive access to the tool (Evidently) at the beginning of the study period or to continue their usual workflow for eight weeks before receiving access. The study does not recruit patients and does not change medical care for patients.
Primary Outcome
Cognitive load measured using the Physician Task Load (PTL) scale, adapted from the National Aeronautics and Space Administration (NASA) Task Load Index. The PTL includes four items-mental demand, physical demand, effort, and time pressure-each rated on a 0-100 scale with reference to a typical clinical workday during the past 1-2 weeks. Item scores will be summed to produce a continuous composite score ranging from 0 to 400, with higher scores indicating greater cognitive workload. The primary
Interventions
- BEHAVIORAL AI Clinical Summarization Tool (Evidently)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2026-06-08 |
| Phase | NA |
What the finished NCT07498582 record still lists
NCT07498582 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which AI Clinical Summarization Tool (Evidently) is the first listed.
NCT07498582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07498582 about?
NCT07498582 is a clinical study titled "AI Tool to Reduce Clinician Documentation Burden". This study looks at whether a clinician-facing artificial intelligence (AI) tool can help outpatient doctors spend less time reviewing medical records and documenting care. The tool creates brief summaries of existing medical record information to support routine clinical work. This study examines h...
What is the current status of trial NCT07498582?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2026-03-30. Estimated completion is 2026-06-08.
What interventions are being tested in trial NCT07498582?
The interventions under investigation include: AI Clinical Summarization Tool (Evidently) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07498582?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07498582's enrollment target sits among peer trials
128 744th of 2000 higher than 1,252 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI